Loader
Latest
Trending
Latest news
Europe
Categories
Programmes
Featured
World
Categories
Programmes
Featured
EU Policy
Business
Categories
Programmes
Featured
Travel
Categories
Programmes
Next
Categories
Programmes
Featured
Culture
Categories
Programmes
Earth
Categories
Programmes
Featured
Health
Categories
Programmes
Euroviews
Videos
More
Special coverage
Partner content
Services
Loader
Find Us
Flipboard Instagram Linkedin
Advertisement

Germany says production capacity, not patents, key to upping vaccine output

Germany says production capacity, not patents, key to upping vaccine output
Germany says production capacity, not patents, key to upping vaccine output -  Copyright  (c) Copyright Thomson Reuters 2021. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Copyright (c) Copyright Thomson Reuters 2021. Click For Restrictions - https://agency.reuters.com/en/copyright.html
By Reuters
Published on
Share Comments Add Euronews on Google
Share Close Button

BERLIN (Reuters) - The main challenge to raising production of COVID-19 vaccines is how to quickly and effectively transfer technology, Germany's health minister said Friday, reiterating Berlin's opposition to a U.S. proposal to waive patent protection.

ADVERTISEMENT
ADVERTISEMENT

"The main issue is not patent protection but production capacity," Jens Spahn told a news conference on Friday.

In a jab at the Biden administration, Spahn also said: "I would be delighted if the United States shows the same willingness to export vaccines that we in Germany do."

(Reporting by Douglas Busvine and Paul Carrel, editing by Riham Alkousaa)

Go to accessibility shortcuts
Share Comments Add Euronews on Google

Read more

Mysterious elephant deaths in Kenya leave experts searching for answers

Migrant charity SOS Méditerranée says 11 bodies spotted in sea off Libya's coast

Luigi Mangione admits shooting healthcare CEO Brian Thompson in New York court